8-K: Bausch + Lomb Launches $600 Million Senior Secured Notes Offering and Major Credit Agreement Refinancing

Bausch + Lomb Corporation announced a significant financial restructuring initiative, including a $600 million senior secured notes offering and a partial refinancing of its credit agreement with new term B and revolving credit facilities totaling $3 billion, aimed at repaying existing debt.

Summary

• Bausch + Lomb Corporation's subsidiaries, Bausch & Lomb Incorporated and Bausch+Lomb Netherlands B.V., launched an offering of $600 million aggregate principal amount of senior secured floating rate notes.
• Concurrently, the company initiated a partial refinancing of its credit agreement, intending to secure a new $2.2 billion term B loan facility and a new $800 million revolving credit facility.
• The net proceeds from the Notes offering and the New Term B Loan Facility, along with borrowings from the New Revolving Credit Facility, are intended to repay outstanding borrowings under its existing revolving credit facility.
• The funds will also be used to fully refinance outstanding term A loans due 2027 and term B loans due 2027, and to cover related fees and expenses.
• Any remaining amounts after debt repayment and expense coverage will be allocated for general corporate purposes.
• The closing of the Notes offering is not contingent upon the closing of the New Term B Loan Facility or the New Revolving Credit Facility.
• The Notes will be guaranteed by Bausch + Lomb and its relevant subsidiaries and will be secured on a first priority basis by liens on the same assets that secure existing credit agreement obligations and the company's 8.375% senior secured notes due 2028.
• The transactions are subject to market and other conditions, with no assurance of successful completion on the described terms or at all.
• The Notes are being offered to qualified institutional buyers in the U.S. (Rule 144A) and non-U.S. persons outside the U.S. (Regulation S), and will not be registered under the Securities Act or Canadian securities laws for public sale.

Sentiment

Score: 6

Explanation: The announcement is a proactive financial management step, indicating the company is actively managing its debt profile. While there's a standard 'no assurance' risk disclosure, the overall intent is positive for capital structure management.

Positives

• The refinancing initiative aims to optimize the company's capital structure by extending maturities and potentially improving debt terms.
• The new facilities provide significant liquidity, with a new $800 million revolving credit facility available for general corporate purposes.
• The non-contingent nature of the Notes offering provides flexibility in the overall refinancing strategy.

Negatives

• The company explicitly states there can be no assurance that the transactions will be successfully completed on the terms described, or at all, due to market and other conditions.

Risks

• The successful completion of the Notes offering, the New Term B Loan Facility, and the New Revolving Credit Facility is subject to market and other conditions.
• There is no assurance that the company will be able to successfully complete these transactions on the terms described or at all.
• The Notes will not be registered under the Securities Act or any state securities laws, limiting their sale to specific types of investors (qualified institutional buyers and non-U.S. persons).

Future Outlook

Bausch + Lomb intends to use the net proceeds from the Notes offering and the New Term B Loan Facility, along with borrowings under the New Revolving Credit Facility, to repay existing outstanding revolving credit facility borrowings, refinance its term A and term B loans due 2027, and cover related fees and expenses, with any remainder for general corporate purposes. However, the completion of these transactions is subject to market and other conditions, and there is no guarantee of success.

Management Comments

• The company intends to use the net proceeds from the Notes offering and the New Term B Loan Facility, together with borrowings under the New Revolving Credit Facility, to repay certain outstanding borrowings under its existing revolving credit facility, to refinance in full its outstanding term A loans due 2027 and term B loans due 2027, and to pay related fees and expenses, with any remaining amounts to be used for general corporate purposes.

Industry Context

This announcement reflects a common corporate finance strategy for large, established companies like Bausch + Lomb, a global eye health leader. Refinancing debt is a routine activity to manage capital structure, optimize interest costs, and extend debt maturities, especially in response to prevailing market interest rates and credit conditions. It allows the company to proactively manage its balance sheet and financial flexibility within the competitive global healthcare and pharmaceutical industry.

Comparison to Industry Standards

• The refinancing of existing debt facilities and issuance of new notes is a standard practice among large, publicly traded companies in the healthcare and pharmaceutical sectors to manage their capital structure and liquidity.
• While specific comparable companies or projects are not detailed in the filing, similar debt management activities are frequently undertaken by peers such as Johnson & Johnson (JNJ), Alcon (ALC), and CooperCompanies (COO) to optimize their financial positions and fund operations or strategic initiatives.

Stakeholder Impact

• Shareholders: Potential impact on the company's cost of capital and financial leverage, which could influence future earnings and valuation.
• Creditors: Refinancing of existing debt will affect current lenders and introduce new lenders for the notes and new loan facilities.
• Employees, Customers, Suppliers: Indirect positive impact from a more stable and optimized financial structure, potentially supporting long-term business operations.

Next Steps

• Completion of the $600 million senior secured floating rate notes offering, subject to market and other conditions.
• Completion of the $2.2 billion New Term B Loan Facility and $800 million New Revolving Credit Facility, subject to market and other conditions.
• Application of net proceeds to repay existing revolving credit facility borrowings, refinance outstanding term A and term B loans due 2027, and pay related fees and expenses.

Key Dates

Keywords

Bausch + Lomb, BLCO, Senior Secured Notes, Refinancing, Credit Agreement, Term Loan, Revolving Credit Facility, Debt Offering, Corporate Finance, Eye Health